{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"],"fields":{"title":{"boost":1000.0},"text":{"boost":1.0},"tags":{"boost":1000000.0}}},"docs":[{"location":"","title":"Home","text":"Personalized Pharmaceutical Care Lab      \uc815\ubc00 \uc758\ud559\uc758 \ubbf8\ub798\ub97c     \uc124\uacc4\ud569\ub2c8\ub2e4.    <p>     \uc720\uc804\uccb4 \ubc1c\uacac\uacfc \uc784\uc0c1 \uc801\uc6a9\uc758 \uad50\ucc28\uc810\uc5d0\uc11c,     \uc6b0\ub9ac\ub294 \ub354 \uc548\uc804\ud558\uace0 \ud6a8\uacfc\uc801\uc778 \uc57d\ubb3c \uce58\ub8cc\ub97c \uc704\ud55c \uae38\uc744 \uc5fd\ub2c8\ub2e4.   </p> \uc5f0\uad6c \ubd84\uc57c \ud0d0\uc0c9 \uc5f0\uad6c\uc9c4 \uc18c\uac1c 01. Precision Medicine <p>\ud658\uc790 \uac1c\uac1c\uc778\uc758 \uc720\uc804\uc801 \ud2b9\uc131\uc5d0 \ub9de\ucd98 \ucd5c\uc801\uc758 \uc57d\ubb3c \uce58\ub8cc\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubd80\uc791\uc6a9\uc740 \ucd5c\uc18c\ud654\ud558\uace0, \ud6a8\uacfc\ub294 \uadf9\ub300\ud654\ud569\ub2c8\ub2e4.</p> 02. Genomics <p>\uc57d\ubb3c \ubc18\uc751\uc758 \uc720\uc804\uc801 \ube44\ubc00\uc744 \ud574\ub3c5\ud558\uc5ec, DNA \ubd84\uc11d\uc744 \ud1b5\ud55c \uc548\uc804\ud55c \uc758\uc57d\ud488 \uac1c\ubc1c\uc744 \uc120\ub3c4\ud569\ub2c8\ub2e4.</p> 03. Big Data &amp; AI <p>\ub300\uaddc\ubaa8 \uc758\ub8cc \ub370\uc774\ud130\ub97c \ubd84\uc11d\ud558\uc5ec \uc784\uc0c1 \uc758\uc0ac\uacb0\uc815\uc744 \uc9c0\uc6d0\ud558\ub294 \uc778\uacf5\uc9c0\ub2a5 \ubaa8\ub378\uc744 \uac1c\ubc1c\ud569\ub2c8\ub2e4.</p> Recent News <p>Publication: ABCG2 Polymorphism \uc5f0\uad6c\uac00 Cardiovascular Toxicology\uc5d0 \uac8c\uc7ac\ub418\uc5c8\uc2b5\ub2c8\ub2e4.</p> \ub354 \ubcf4\uae30 Principal Investigator \uae40\uc6b0\ub9bc \uad50\uc218 <p>\uc57d\ud559\ub300\ud559 \uc870\uad50\uc218</p> <p>         \uc911\uac1c \uc57d\ubb3c\uc720\uc804\uccb4\ud559 \uc5f0\uad6c\ub97c \uc774\ub04c\uba70, \uae30\ucd08 \uacfc\ud559\uacfc \uc784\uc0c1 \ud604\uc2e4 \uc0ac\uc774\uc758 \uac04\uadf9\uc744 \uc881\ud788\uace0 \uc788\uc2b5\ub2c8\ub2e4.       </p>"},{"location":"contact/","title":"Contact Us","text":""},{"location":"contact/#address","title":"Address","text":"<p>Personalized Pharmaceutical Care Lab College of Pharmacy, Kangwon National University 1 Kangwondaehak-gil, Chuncheon-si, Gangwon-do, Republic of Korea</p>"},{"location":"contact/#email","title":"Email","text":"<p>woorimkim@kangwon.ac.kr</p>"},{"location":"members/","title":"The Team","text":""},{"location":"members/#principal-investigator","title":"Principal Investigator","text":"Woorim Kim, Ph.D. <p>Assistant Professor</p> <p>College of Pharmacy, Kangwon National University</p> <p>\ud83d\udce7 woorimkim@kangwon.ac.kr</p> Faculty Profile"},{"location":"members/#researchers","title":"Researchers","text":"Researcher Name <p>Postdoctoral Fellow</p> <p>Focus: Pharmacogenomics</p> Researcher Name <p>Ph.D. Candidate</p> <p>Focus: AI Analytics</p>"},{"location":"members/#graduate-students","title":"Graduate Students","text":"Student Name <p>Master's Student</p> Student Name <p>Master's Student</p> <p></p>"},{"location":"members/#lab-life","title":"Lab Life","text":""},{"location":"publications/","title":"Publications","text":""},{"location":"publications/#2025","title":"2025","text":"<ul> <li> <p>Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-AnalysisLee Da, Shin Hae, Yoon Beom, Kim WoorimCardiovascular Toxicology. 2025;25(11):1761--1767.</p> </li> <li> <p>One-Year Risk of Bleeding in Patients on a Stable Warfarin Dose After Prosthetic Heart Valve SurgeryMin Kyung, Kim Woorim, Kim Jun, Gil Jin, Choi Kyung, Han Ji, Lee KyungPharmacoepidemiology and Drug Safety. 2025;34(9).</p> </li> <li> <p>Factors inducing cutaneous adverse reactions in cancer patients treated with PD-1 and PD-L1 inhibitors: a machine-learning algorithm approachCho Young-Ah, Moon Youngyun, Park Wooyoung, Lee Yerin, Lee Kyung-Eun, Kim Dong-Chul, Kim WoorimImmunopharmacology and Immunotoxicology. 2025;47(1):53--58.</p> </li> </ul>"},{"location":"publications/#2024","title":"2024","text":"<ul> <li> <p>Development of a Risk Prediction Model for Adverse Skin Events Associated with TNF-\u03b1 Inhibitors in Rheumatoid Arthritis PatientsKim Woorim, Oh Soo-Jin, Kim Hyun-Jeong, Kim Jun-Hyeob, Gil Jin-Yeon, Ku Young-Sook, Kim Joo-Hee, Kim Hyoun-Ah, Jung Ju-Yang, Choi In-Ah, Kim Ji-Hyoun, Kim Jinhyun, Han Ji-Min, Lee Kyung-EunJournal of Clinical Medicine. 2024;13(14).</p> </li> <li> <p>Risk factors for hyperglycemia in COVID-19 patients treated with remdesivirKim Woorim, Lee Go, Rhee Nuga, Min Kyung, Kim Jun, Gil Jin, Lee KyungClinical and Translational Science. 2024;17(1):e13684.</p> </li> </ul>"},{"location":"publications/#2023","title":"2023","text":"<ul> <li> <p>Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor TherapyKim Woorim, Cho Young, Min Kyung, Kim Dong-Chul, Lee Kyung-EunPharmaceuticals. 2023;16(8):1097.</p> </li> <li> <p>Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-\u03b1 inhibitors: a machine learning approachKim Woorim, Yeon Ha, Kim Jun, Kim Joo, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee KyungImmunologic Research. 2023;71(5):709--716.</p> </li> </ul>"},{"location":"publications/#2022","title":"2022","text":"<ul> <li> <p>Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-\u03b1 inhibitors and utilization of machine-learning algorithmsKim Woorim, Oh Soo, Trinh Nga, Choi Yunjeong, Kim Jun, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee KyungInternational Immunopharmacology. 2022;111:109094.</p> </li> <li> <p>COVID-19 Prognosis in Association with Antidepressant UseMin Kyung, Kim Tae, Oh Soo, Kim Woorim, Lee KyungPharmacopsychiatry. 2022;55(04):220--227.</p> </li> <li> <p>Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-AnalysisKim Woorim, Cho Young-Ah, Kim Dong-Chul, Lee Kyung-EunPharmaceuticals. 2022;15(4):489.</p> </li> <li> <p>Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-AnalysisKim Woorim, Cho Young-Ah, Kim Dong-Chul, Lee Kyung-EunJournal of Personalized Medicine. 2022;12(2):235.</p> </li> <li> <p>Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitorsKim Woorim, Kim Hyun, Trinh Nga, Yeon Ha, Kim Joo, Choi In, Kim Hyoun-Ah, Jung Ju-Yang, Lee KyungPharmacogenetics and Genomics. 2022;32(1):10--15.</p> </li> </ul>"},{"location":"publications/#2021","title":"2021","text":"<ul> <li> <p>Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning ModelsKim Woorim, Cho Young-Ah, Kim Dong-Chul, Jo A-Ra, Min Kyung-Hyun, Lee Kyung-EunCancers. 2021;13(21):5465.</p> </li> <li> <p>Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-\u03b1 inhibitors and development of machine learning modelsKim Woorim, Kim Tae, Oh Soo, Kim Hyun, Kim Joo, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee KyungScientific Reports. 2021;11(1):20169.</p> </li> <li> <p>TGF-\u03b21 polymorphism increases the risk of bleeding complications in patients on oral anticoagulant after cardiac valve replacementKim Woorim, Yee Jeong, Chang Byung-Chul, Gwak HyeHeart and Vessels. 2021;36(12):1885--1891.</p> </li> <li> <p>Association of risk factors and bleeding complications in Asian patients taking edoxabanLee Ok, Kim Woorim, Jang Bo, Min Kyung, Cho Yoon, Lee Myung, Lee KyungBritish Journal of Clinical Pharmacology. 2021;87(4):2121--2127.</p> </li> </ul>"},{"location":"research/","title":"Research Sectors","text":"Personalized Medicine <p>We investigate individual variability in drug response due to genetic, environmental, and physiological factors. Our goal is to develop predictive models for drug efficacy and toxicity.</p> Pharmacogenomics (PGx) <p>We identify genetic markers associated with drug response. By analyzing genomic data, we aim to implement PGx testing in clinical practice to prevent adverse drug reactions.</p> Clinical Pharmacology <p>We conduct pharmacokinetic (PK) and pharmacodynamic (PD) modeling to optimize dosage regimens for various patient populations, including pediatrics and the elderly.</p> Pharmacoepidemiology <p>Using real-world data (RWD) and big data analytics, we evaluate the safety and effectiveness of medications in large populations.</p>"},{"location":"en/","title":"EN","text":"Personalized Pharmaceutical Care Lab      Designing the Future     of Precision Medicine.    <p>     At the intersection of genomic discovery and clinical application,     we pave the way for safer and more effective drug therapies.   </p> Explore Research Meet the Team 01. Precision Medicine <p>Tailoring medical treatment to individual genetic characteristics. Minimizing risks while maximizing efficacy.</p> 02. Genomics <p>Decoding the genetic secrets of drug response to lead the development of safe medications through DNA analysis.</p> 03. Big Data &amp; AI <p>Leveraging large-scale healthcare data to develop AI models that support clinical decision-making.</p> Recent News <p>Publication: Our work on ABCG2 Polymorphism has been accepted in Cardiovascular Toxicology.</p> Read More Principal Investigator Prof. Woorim Kim <p>Assistant Professor, College of Pharmacy</p> <p>         Leading translational pharmacogenomics research, bridging the gap between basic science and clinical reality.       </p>"}]}